Design and development of an aptamer targeting C-type lectin-like molecule-1 as a biomarker for acute myeloid leukemia: a SELEX approach
Acute myeloid leukemia (AML), a hematologic malignancy, is an important public health issue. It is a result of the abnormal proliferation of immature myeloid cells. Despite advancements in diagnostic procedures, the early identification of AML remains a significant clinical challenge, marking a dist...
Saved in:
Main Authors: | Yiwen Chen, Qinhang Li, Shifeng Lou, Hanqing Zeng, Shu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-08-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2025.1601453/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress in Aptamer Research and Future Applications
by: Song Liu, et al.
Published: (2025-07-01) -
Advancements in SELEX Technology for Aptamers and Emerging Applications in Therapeutics and Drug Delivery
by: Liangjie Feng, et al.
Published: (2025-06-01) -
The Power of Old Hats: Rediscovering Inosine-EpPCR to Create Starting Libraries for Whole-Cell-SELEX
by: Grigory Bolotnikov, et al.
Published: (2025-07-01) -
Aptamer-based diagnostics and therapeutics in viral sepsis: current progress, application and future prospects
by: Noraini Abd-Aziz, et al.
Published: (2025-01-01) -
Development of DNA aptamer selection approach based on membrane ultrafiltration of aptamer/target complex
by: I. S. Solovarov, et al.
Published: (2022-12-01)